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Abstract We studied whether the TGF-~-induced apoptosis in 
fetal hepatocyte primary cultures may be modulated by the 
presence of mitogenic stimuli, such as EGF or HGF. EGF 
prevented cell death, showing a dose dependence that was 
identical to that observed for its effect on DNA synthesis 
stimulation. HGF, in contrast, had no effect, even at high 
concentrations. EGF blocked apoptosis, since in the presence of 
this factor cells did not show DNA fragmentation. Moreover, 
EGF, but not HGF, blocked c-fos induction associated with the 
apoptotic process induced by TGF-13 in these cells. 
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1. Introduction 
Apoptosis, or programmed cell death, is essential in many 
aspects of normal development and is required for maintaning 
homeostasis [1]. Because apoptosis plays a critical role in de- 
leting cells from tissues, it is not surprising that failure of 
apoptosis leads to imbalanced cell proliferation and is now 
recognized as a mechanism of carcinogenesis. Lethal cellular 
programs that lead to apoptosis may be triggered by a variety 
of exogenous and environmental stimuli. As in all biological 
systems, there are activators and inhibitors, growth factors 
and cytokines clearly playing an important regulatory role. 
During recent years, increasing evidence supports a role of 
apoptosis in normal iver biology and as a pathophysiological 
mechanism of cell death during hepatobiliary disease (for a 
review, see [2]). However, very little is known about the pos- 
sible role of apoptosis during the growth and differentiation f 
fetal liver. 
Transforming growth factor-beta (TGF-I]) is one of the best 
known physiological inhibitors of epithelial cell proliferation 
and recent interest has been focused on its possible role in cell 
death. It is a member of a large family of structurally related 
factors that play a critical role during embryogenesis in mam- 
mals, frogs and flies [3,4]. We have reported that TGF-13 in- 
hibits the epidermal growth factor (EGF) - and/or hepato- 
cyte growth factor (HGF) - induced DNA synthesis in fetal 
hepatocytes in primary culture [5,6] and modulates proto-on- 
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cogene and liver-specific gene expression in these cells [7,8]. 
However, TGF-13 might have other functions in the liver, since 
higher concentrations of this factor both inhibit proliferation 
and increase apoptosis in fetal [9] and adult [10] rat hepato- 
cytes and in hepatoma cells [11]. Cell proliferation occurs 
during stimulation of fetal or regenerating hepatocytes by 
mitogens uch as TGF-a, EGF or HGF [5,6,12]. It has been 
described that when the mitogenic stimulus is withdrawn in 
vivo, the excess cells are removed by apoptosis, resulting in a 
regression of the original hyperplasia [13]. However, it is not 
yet clear if all growth factors may be survival factors for the 
liver. 
In this work we have studied whether TGF-13-induced 
apoptosis may be modulated by the presence of mitogenic 
stimuli, such as EGF or HGF, in fetal hepatocytes in primary 
culture. The results show that both mitogens behave in a 
different manner. Whereas EGF blocks apoptosis induced 
by TGF-13, HGF does not. This is the first evidence of a 
differential response of fetal hepatocytes to EGF and HGF, 
which clearly might implicate differential roles for both mito- 
gens during liver development, regeneration a d hepatocarci- 
nogenesis. 
2. Materials and methods 
2.1. Materials 
TGF-13 was from Austral Biologicals (San Ramon, CA). Collage- 
nase was from Boehringer (Mannheim, Germany). Fetal and neonatal 
calf serum and culture media were from Imperial Laboratories 
(Hampshire, UK). Radiochemicals were from ICN (Irvine, CA). Mul- 
tiprimer DNA labeling system was from Amersham (Buckingham- 
shire, UK). The nick-translation labeling system was from Gibco 
BRL (Gaithersburg, USA). 
2.2. Isolation and culture of fetal rat hepatocytes 
Hepatocytes from 20-day old fetal Wistar rats were isolated and 
plated in arginine-free M-199 medium as previously described [5,14]. 
Cells were incubated in 5% CO2, at 37°C for 4 h, allowing cell attach- 
ment o plates. The medium was changed at that time and replaced by 
one of the same composition except that the 10% fetal calf serum was 
replaced with 2% newborn bovine serum. After 18-20 h, the medium 
was again replaced for one of identical composition but in the absence 
of serum. 2 h later, growth factors were added. 
2.3. TGF-[$-mediated cytotoxicity assay 
After cell incubation in the absence or presence of the different 
factors, the medium was discarded and the remaining viable adherent 
cells were stained with crystal violet (0.2% in 2% ethanol) for 20 min, 
as previously described [15]. Remaining viable cells were calculated as 
% absorbance with respect to control cells (incubated in the absence 
of growth factors). 
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2.4. DNA synthesis assay 
After incubation of the cells for 48 h in the absence or presence of 
the mitogen, DNA synthesis was evaluated by [SH]thymidine incor- 
poration into trichloroacetic acid-precipitable material, as we have 
previously described [5]. 
2.5. Analysis of nuclear DNA content by flow cytometry 
The ploidy determination of hepatocyte nuclei was estimated by 
flow cytometry DNA analysis as previously described [5]. Cells were 
detached from dishes by addition of 0.25% trypsin-0.02% EDTA and 
the DNA content per nucleus was evaluated in a FACSCAN flow 
cytometer (Becton-Dickinson, San Jose, CA), after using the Cycle 
test DNA reagent kit (Becton- Dickinson) to stain nuclei with propi- 
dium iodide. For the computer analysis, only signals from single nu- 
clei were considered (10000 nuclei/assay). 
2.6. Analysis of DNA fragmentation 
A modified version of the method of Lyons et al. [16] was used to 
assess the fragmentation of hepatocyte DNA. Rat fetal hepatocytes 
were washed twice with PBS, then scraped and pelleted at 4°C. Cells 
were resuspended in 500 ~tl of buffer containing 10 mM EDTA, 0.25% 
Triton X-100, 2.5 mM Tris-HC1, pH 8.0 and stored at 4°C for 15 min. 
Intact nuclei were pelleted and eliminated by centrifugation at 500 × g 
for 10 min and the supernatant centrifuged at 25 000 × g at 4°C for 30 
min. DNA in the supernatant was precipitated at -80°C after addi- 
tion of 2 vols. of ethanol (70% final concentration), pelleted by micro- 
centrifugation at4°C for 15 min, dried, resuspended in 200 I.tl 10 mM 
Tris-HC1, 1 mM EDTA, pH 8.0 (TE buffer) and incubated at 37°C for 
30 min with 0.1 mg/ml RNAse A and for 2-3 h with 0.25 mg/ml 
proteinase K. DNA was purified by phenol-chloroform extraction 
and precipitated at -70°C after adding (1/10 vol. of) 3 M sodium 
acetate, pH 5.3 and (2 vols. of) ethanol. Precipitated DNA was dis- 
solved in TE buffer containing 30% glycerol, 1 ktg/ml ethidium bro- 
mide and electrophoresed in a 1.5% agarose gel. The gel was visua- 
lized and photographed under transmitted UV light with a Polaroid 
camera. 
2.7. RNA Isolation and Northern blot analysis 
Total RNA was isolated as described by Chomczynski and Sacchi 
[17]. For each assay, RNA was extracted from the pooled cells of two 
92 mm diameter dishes, denatured in 50% formamide, 2.2 M formal- 
dehyde, 20 mM MOPS, pH 7.0, 6% glycerol at 65°C for 15 min, 
separated by size on gels containing 0.9% agarose and 0.66 M for- 
maldehyde and blotted on GeneScreen membranes (NEN Research 
Products, Dupont, Boston MA). Hybridizations were performed as 
previously described [7]. ¢t-Fetoprotein [18], albumin [19] and 18S 
ribosomal [20] cDNAs were labeled with [tx-32P]dCTP by nick-trans- 
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Fig. 1. Effect of epidermal growth factor or hepatocyte growth fac- 
tor on cell death induced by TGF-[3 in rat fetal hepatocytes in pri- 
mary culture. Cells were cultured in the absence or presence of 
1 ng/ml TGF-[I (T), 20 ng/ml EGF (E), 10 ng/ml HGF (H), or the 
combination of EGF and TGF-[~ (E+T), or HGF and TGF-[3 
(H+T) for 24 h. After this time cells were stained with crystal violet 
and the viability was quantified as described in section 2. Results 
are expressed as % of control and are means + S.E.M. from three in- 
dependent experiments of triplicate dishes. 
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Fig. 2. (A) Dose-response analysis of the effect of EGF or HGF on 
the apoptosis induced by TGF-[3 in fetal hepatocytes. After culture 
of cells for 24 h in the presence of 1 ng/ml TGF-13 and in the ab- 
sence or presence of different concentrations of EGF (e) or HGF 
(©), cell viability was calculated as described in Fig. 1. (B) Dose-re- 
sponse analysis of the mitogenic effect of EGF or HGF. After cul- 
ture of cells for 48 h in the absence or in the presence of different 
concentrations of EGF (e) or HGF (G), DNA synthesis was calcu- 
lated by [aH]thymidine incorporation as described in section 2. In 
both (A) and (B), results are expressed as % control (untreated) 
cells and are a representative experiment of at least three. 
lation, whereas v-fos [21], H-ras, [22] and HNF-4 [23] were labeled by 
random priming reaction. Serial hybridizations with the different 
probes were performed succesively. 
3. Results and discussion 
3.1. Effect of growth factors on cell death induced by TGF-[$ in 
fetal hepatocytes 
We have previously reported that TGF-  13 regulates death of 
fetal hepatocytes in pr imary culture [8]. These cells die in the 
presence of the factor in a dose-dependent manner,  presenting 
clear evidence of the involvement of an apoptotic process [9]. 
However, nothing is known about the possible protective role 
of growth factors on TGF-l~-induced apoptosis in hepato- 
cytes. For  this reason, as a first approach we investigated 
whether or not known mitogenic factors for these cells could 
prevent TGF-~- induced cell death. When hepatocytes ex- 
tracted from 20-day-old fetuses were incubated for 24 h in 
the presence of 1 ng/ml TGF-I], 50% of the cells died. A 
similar result was observed when TGF-B was combined with 
10 ng/ml HGF.  However, in the presence of 20 ng/ml EGF,  
TGF-~ was ineffective, the percentage of viable cells being 
maintained as in control cells (Fig. 1). 
A dose-dependence study of the EGF-protect ive ffect on 
cell death induced by TGF-I] showed that low concentrations 
of the factor did not have any effect. Concentrat ions of 1-20 
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Fig. 3. Effect of EGF on TOF-~-induced DNA fragmentation. 
(A) Nuclear DNA content of untreated cells, or cells that were trea- 
ted for 12 h with either 1 ng/ml TGF-~ alone or TGF- I] in combi- 
nation with 20 ng/ml EGF was analysed by propidium iodide stain- 
ing in a flow cytometer. The DNA profiles of a representative 
experiment (of four) are shown (B). After 12 h incubation of fetal 
hepatocytes in the absence (1) or presence of TGF-13 (2) or TGF-13 
and EGF (3) cells were lysed and low molecular weight DNA iso- 
lated, subjected to gel electrophoresis on a 1.5% agarose gel and vi- 
sualized by UV fluorescence after staining with ethidium bromide. 
A representative experiment of three is shown. 
ng/ml showed a progressive protective ffect hat became max- 
imal at 10-20 ng/ml, where cell death was totally abolished 
(Fig. 2A). This dose dependence was identical to that ob- 
served for the DNA synthesis timulated by EGF in these 
cells (Fig. 2B). In contrast, HGF did not have any effect 
even at concentrations higher than those necessary for obtain- 
ing the maximal response in terms of cell proliferation (Fig. 
2). 
In our previous tudies on apoptosis elicited by TGF-13 we 
had seen that TGF-~ at apoptotic doses induced changes in 
cell morphology. Hepatocytes responded to TGF-13 with an 
initial loss of cell contacts and migration, followed by degen- 
eration and detachment [9]. HGF did not have any influence 
on such morphological effects, while cells treated with TGF-13 
in combination with EGF were perfectly attached to dishes, 
showing intact morphology (results not shown). 
3.2. EGF prevents DNA fragmentation i duced by TGF-~ in 
fetal hepatocytes inprimary culture 
In order to assess whether EGF was really blocking the 
apoptotic process elicited by TGF-13, we first analyzed the 
nuclear DNA content by flow cytometry, staining nuclei 
with propidium iodide. Cells that had been incubated for 12 
h in the presence of TGF-I] showed a significant percentage 
(about 20-25%) of nuclei with a DNA content lower than 2C, 
in contrast to 2-3% in control (untreated) cells. In contrast, in 
the presence of TGF-[3 and EGF the percentage of nuclei with 
a DNA content lower than 2C disminished to 8-10%, an 
important decrease with respect o TGF-13 alone (a represen- 
tative experiment is shown in Fig. 3A). 
In an alternative approach, we analyzed if EGF was also 
able to prevent DNA fragmentation induced by TGF-13. Low 
molecular weight DNA was extracted from parallel dishes 
that had been incubated in the absence or presence of TGF- 
13 alone or in combination with EGF, and examined by elec- 
trophoresis. Cells that were treated with TGF-13 for 12 h 
showed the typical DNA ladder. In contrast, DNA fragmen- 
tation in cells treated with EGF and TGF-13 was not observed 
(Fig. 3B). 
All these results suggest hat EGF prevents the apoptosis 
induced by TGF-I] in fetal hepatocytes, presenting a dose 
dependence that is similar to that observed for its mitogenic 
activity. EGF and TGF-(z also inhibit the onset of apoptotic 
DNA cleavage found in other cell models, such as cultured rat 
ovarian granulosa cells [24] or mammary epithelial cells [25]. 
3.3. EGF, but not HGF, suppresses TGF-~ induction of c-fos 
mRNA levels in fetal hepatocytes in primary culture 
We had observed that apoptotic oncentrations of TGF-13 
induced c-fos expression in fetal hepatocytes, that was max- 
imal 24-48 h after adding the factor [9]. It therefore seemed of 
interest to study whether EGF also prevented the induction of 
c-fos expression. For this purpose, total RNA extracted from 
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Fig. 4. Role of EGF and HGF in the changes in gene xpression i - 
duced by TGF-13 in fetal hepatocytes in primary culture. Cells were 
cultured in the absence or presence of 1 ng/ml TGF-[3, 20 ng/ml 
EGF, 10 ng/ml HGF, or the combination of TGF-13 and EGF or 
TGF-~3 and HGF. After 24 h of treatment, total RNA was isolated 
and 10 Ixg were subjected to Northern blot analysis using the 
cDNA probes pecific for c-fos, H-ras, o~-fetoprotein (AFP), albumin 
(ALB) and HNF-4 mRNAs. 18S Ribosomal probe was used for 
RNA normalization. A representative experiment of three is shown. 
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cells incubated for 24 h in the presence of the different factors 
was subjected to Northern blot analysis. Cells under treatment 
with TGF-~ alone showed induced levels of c-fos mRNA (Fig. 
4). In agreement with the results observed previously in the 
viability analysis, cells that were treated with HGF and TGF- 
presented similar c-fos mRNA levels. In contrast, the pre- 
sence of EGF completely prevented c-fos induction. This dif- 
ference in c-fos expression between EGF- and HGF- treated 
cells was specific, since the mRNA levels of other proto-on- 
cogenes, such as H-ras (Fig. 4), c-myc and c-met (results not 
shown) were similar in cells that were treated with either 
EGF+TGF-~ or HGF+TGF-IS. Elevated expression of c-fos 
has previously been related to programmed cell death [26]. 
The time course analysis of c-fos mRNA levels showed that 
in TGF-I~-treated fetal hepatocytes its gene expression in- 
creased just when cells stopped dying [9]. So, we speculated 
that c-fos might be a survival gene involved in the hepatocyte 
response to TGF-I3. Regardless of its role in the apoptotic 
process, the results presented here clearly show that EGF 
prevents the TGF-13-induction of this gene. 
The analysis of the mRNA levels of liver differentiation- 
related genes, such as ct-fetoprotein (AFP), albumin (ALB) 
or transcription factor HNF-4, showed that TGF-I~-treated 
cells clearly lost their expression. However, when EGF or 
HGF were present, the expression of these liver-specific genes 
was maintained (Fig. 4). We have recently described that 
TGF-~, at low concentrations, acts synergistically with EGF 
and/or HGF maintaining the differentiation state of the fetal 
hepatocytes [8]. The present results show that this effect can 
also be observed at higher concentrations of TGF-~ (Fig. 4), 
regardless of whether or not apoptosis was observed. 
HGF and EGF are both motogenic and mitogenic for he- 
patocytes in vitro. However, the spatial and temporal differ- 
ences exhibited between the two growth factors in terms of 
signal transduction [27,28], as well as their additive effects on 
hepatocytes in vitro [6,12] strongly suggest that they probably 
accomplish their effects via redundant as well as divergent 
signal transduction mechanisms. The differences between their 
role in the TGF-lS-induced apoptosis presented in this paper 
may have clear implications during liver development and 
regeneration or hepatocarcinogenesis. Apoptosis is essential 
in many aspects of normal development and is required for 
maintaining homeostasis. Thus, too much or too little cell 
death may have negative consequences. Hepatic TGF-~ gene 
expression is developmentally regulated. A high level of ex- 
pression of TGF-~ mRNA is found in the liver during mid- 
gestation; it decreases with increasing fetal maturity and de- 
creases further in the postnatal period [29]. Quiescent liver has 
very low TGF-~ mRNA levels, but normal regenerating, neo- 
plastic proliferating and carcinogen-treated liver all have in- 
creased levels of TGF-~ gene transcripts [30]. Thus, it has 
been proposed that TGF-~ may be the principal counter-reg- 
ulator of hepatocyte proliferation during liver regeneration 
[29]. In accordance with the results shown in this paper, 
EGF (or TGF-~) might play an important role during early 
liver development, not only acting as an important mitogen, 
but also allowing cells to overcome apoptosis and differen- 
tiate. HGF, in contrast, might play a more important role 
in the regenerating liver, where apoptosis elicited by TGF-~ 
might be necessary to counteract the high proliferative rate. 
Under these conditions, HGF, in addition to its role as an 
important mitogen in the first steps during liver regeneration, 
could have an additional role to play later on, i.e. allowing 
TGF-I~ to eliminate cells and acting synergistically with this 
factor in differentiating those cells that survive to the pro- 
grammed cell death. 
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